Japan· JP-1149026F2206
オキサプロジン
A oxaprozin product containing オキサプロジン, registered in Japan by 大正製薬, on the national reimbursement list. The same ATC class is registered in 4 of our 19 countries.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
Where it is registered
Oxaprozin is registered in 4 of 19 countries.
Countries holding a registration under ATC M01AE12 (oxaprozin), each read from that country’s own register.
- This record: Japan, from MHLW / PMDA (Japan)
- 3 of them publish a price we can compare per daily dose
Oxaprozin · ATC M01AE12
4 / 19 countries
- Belgiumprice
- Finlandprice
- Japan
- United Statesprice
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- オキサプロジン
- Manufacturer
- 大正製薬
- Country
- Japan (JP)
- ATC code
- M01AE12
- ATC class
- Oxaprozin
- Defined daily dose
- 0.9 g, O
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
245 interactions on record for oxaprozin.
Graded by severity as the source publishes them — 57 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Oxaprozin · interactions on record
245 records
- 57 severe
- 140 moderate
- 5 minor
- 43 info
Most severe, free to view
- DicoumarolB01AA01severe
- WarfarinB01AA03severe
- DalteparinB01AB04severe
- EnoxaparinB01AB05severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under M01AE12
Oxaprozin, as other registers publish it.
- United StatesCOXANTOSOLA Pharmaceuticals, LLC
- FinlandDuraproxSchering Oy
- FinlandDuraproxSchering Oy
- BelgiumDuraprox 600 mgTramedico
- United StatesOxaprozinDr. Reddy's Laboratories Limited
- United StatesOxaprozinAmneal Pharmaceuticals NY LLC
- United StatesOxaprozinProficient Rx LP
- United StatesOxaprozinST MARY'S MEDICAL PARK PHARMACY
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bc7c859c-15b5-48d5-9359-89f7efdad781 GET /v1/drugs/bc7c859c-15b5-48d5-9359-89f7efdad781?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "２００ｍｇ１錠",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "1149026F2206",
"category": "内用薬",
"price_yen": 18.4,
"generic_name": "オキサプロジン",
"product_name_jp": null,
"therapeutic_class": "1149",
"transitional_expiry": null
}See everything about oxaprozin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.